Target
Apelin receptor
Ligand
BDBM481013
Substrate
n/a
Meas. Tech.
[35S]GTPγS Binding Assay
EC50
170±n/a nM
Citation
 Chen, NChen, YDebenedetto, MVDransfield, PJHarvey, JSHeath, JAHouze, JKhakoo, AYLai, SMa, ZNishimura, NPattaropong, VSwaminath, GYeh, WKreiman, C Triazole phenyl compounds as agonists of the APJ receptor US Patent  US10906890 Publication Date 2/2/2021 
Target
Name:
Apelin receptor
Synonyms:
AGTRL1 | APJ | APJ_HUMAN | APLNR | Angiotensin receptor-like 1 | Apelin receptor | Apelin receptor (APJ) | G-protein coupled receptor APJ | G-protein coupled receptor HG11
Type:
Enzyme Catalytic Domain
Mol. Mass.:
42664.06
Organism:
Homo sapiens (Human)
Description:
P35414
Residue:
380
Sequence:
MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRSSREKRRSADIFIASLAVADLTFVVTLPLWATYTYRDYDWPFGTFFCKLSSYLIFVNMYASVFCLTGLSFDRYLAIVRPVANARLRLRVSGAVATAVLWVLAALLAMPVMVLRTTGDLENTTKVQCYMDYSMVATVSSEWAWEVGLGVSSTTVGFVVPFTIMLTCYFFIAQTIAGHFRKERIEGLRKRRRLLSIIVVLVVTFALCWMPYHLVKTLYMLGSLLHWPCDFDLFLMNIFPYCTCISYVNSCLNPFLYAFFDPRFRQACTSMLCCGQSRCAGTSHSSSGEKSASYSSGHSQGPGPNMGKGGEQMHEKSIPYSQETLVVD
  
Inhibitor
Name:
BDBM481013
Synonyms:
US10906890, Example 22.0
Type:
Small organic molecule
Emp. Form.:
C25H26FN7O4S
Mol. Mass.:
539.582
SMILES:
COc1cccc(OC)c1-n1c(NS(=O)(=O)[C@@H]2CCCN(C2)c2ncc(F)cn2)nnc1-c1ccccc1 |r,wD:16.16,(-7.87,-3.1,;-6.53,-3.87,;-5.2,-3.1,;-5.2,-1.56,;-3.86,-.79,;-2.53,-1.56,;-2.53,-3.1,;-1.2,-3.87,;.14,-3.1,;-3.86,-3.87,;-3.86,-5.41,;-2.62,-6.31,;-1.13,-5.91,;-.04,-7,;1.05,-8.09,;-1.13,-8.09,;1.05,-5.91,;.65,-4.42,;1.74,-3.34,;3.22,-3.73,;3.62,-5.22,;2.53,-6.31,;5.11,-5.62,;5.51,-7.11,;7,-7.51,;8.09,-6.42,;9.57,-6.82,;7.69,-4.93,;6.2,-4.53,;-3.09,-7.77,;-4.63,-7.77,;-5.11,-6.31,;-6.6,-5.91,;-7,-4.42,;-8.48,-4.03,;-9.57,-5.11,;-9.17,-6.6,;-7.69,-7,)|
Structure:
Search PDB for entries with ligand similarity: